| Literature DB >> 33920935 |
Humberto Castillo Quezada1, Cristian Martínez-Salazar2, Sergio Fuentealba-Urra1, Claudio Hernández-Mosqueira2, Nelson Araneda Garcés3, Fernando Rodríguez-Rodríguez4, Yeny Concha-Cisternas5,6, Edgardo Molina-Sotomayor7.
Abstract
INTRODUCTION: The effect of two physical training methods on older adults should be investigated in greater depth and its results shared with the community.Entities:
Keywords: aerobic capacity; cognitive state; muscular strength; older adult
Year: 2021 PMID: 33920935 PMCID: PMC8071321 DOI: 10.3390/ijerph18084186
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Sample recruitment scheme. Control Group GC: the aerobic training group GA: the resistance training group GF
Aerobic Exercise Program.
| Weeks | 1–2–3 | 4–5–6 | 7–8–9 | 10–11–12 |
| Intensity | Under | Moderate | Moderate strong | Moderate to vigorous |
| Volume (min) | 30 | 35 | 40 | 45 |
| Parameters for Intensity control | ||||
| % Maximum Heart Rate | 50 | 60 | 65 | 70 |
| Subjective perception of effort (Borg scale) | 10–11 | 12–13 | 14–15 | 14–15 |
Muscle Strength Exercise Program.
| Weeks | 1–3 | 4–6 | 7–9 | 10–12 |
| Intensity % maximum load | 50% | 50–60% | 60% | 60% |
| Repetitions | 10 | 10–12 | 12–15 | 15 |
| N° Series | 2 | 3 | 3–4 | 4 |
| Recovery (Pause) | 3 min | 2.30–3 min. | 2–2.5 min. | 1.5–2 min. |
Intergroup comparison of aerobic capacity (VO2max), maximum muscular strength (MS) of upper limbs (UL), lower limbs (LL), cognitive state (MMSE), and growth factor concentration (IGF-1). Pre-test.
| Variables | CG ( | AG ( | RG ( | Comparison Intergroup § | |||||
|---|---|---|---|---|---|---|---|---|---|
| M ± SD | CI (95%) | M ± SD | CI (95%) | M ± SD | CI (95%) | F | Partial Eta2 | ||
| MS UL (kg) | 13.67 ± 1.91 | 12.61–14.73 | 14.40 ± 2.38 | 13.08–15.72 | 14.29 ± 2.58 Kg | 12.79–15.78 | 0.437 | 0.649 | 0.1 |
| MS LL (kg) | 44.53 ± 3.50 | 42.59–46.47 | 47.20 ± 3.91 | 45.03–49.37 | 47.43 ± 3.88 Kg | 45.19–49.67 | 2.701 | 0.079 | 0.4 |
| VO2max. (mL kg1 min−1) | 16.13 ± 1.80 | 15.14–17.13 | 16.02 ± 2.06 | 14.88–17.16 | 16.69 ± 1.10 | 16.06–17.32 | 0.625 | 0.540 | 0.2 |
| MMSE (Score) | 24.33 ± 3.52 | 22.38–26.28 | 26.80 ± 2.76 | 25.27–28.33 | 26.43 ± 2.65 | 24.90–27.96 | 2.912 | 0.066 | 0.5 |
| IGF-1 (ng mL−1) | 91.41 ± 23.10 | 78.61–23.10 | 107.88 ± 28.56 | 92.07–123.69 | 105.42 ± 39.08 | 82.86 -127.99 | 1.246 | 0.298 | 0.2 |
M ± SD = means and standard deviation; CI = confidence interval (CI 95%); § = one-factor multivariate analysis (Group); Eta2 = effect size.
Intergroup comparison of aerobic capacity (VO2max), maximum muscular strength (MS) of upper limbs (UL), lower limbs (LL), cognitive state (MMSE), and growth factor concentration (IGF-1). Post-test.
| Variables | CG ( | AG ( | RG ( | Comparison Intergroup § | |||||
|---|---|---|---|---|---|---|---|---|---|
| M ± SD | CI (95%) | M ± SD | CI (95%) | M ± SD | CI (95%) | F | Eta2 Partial | ||
| MS UL (kg) | 13.47 ±2.77 b.c | 11.93–15.00 | 21.40 ± 4.75 a.c | 18.77–24.03 | 23.57 ± 4.13 a.b | 21.19–25.95 | 26.443 | 0.000 | 0.7 |
| MS LL (kg) | 44.13 ± 4.69 b.c | 41.54–46.73 | 64.33 ± 18.46 a | 54.11–74.56 | 77.79 ± 26.07 a | 62.73–92.84 | 25.506 | 0.000 | 0.6 |
| VO2max. (mL.kg1.min−1) | 15.79 ± 2.15 | 11.60–16.98 | 16.59 ± 1.43 | 15.80–17.38 | 16.91 ± 1.02 | 16.32–17.50 | 1.885 | 0.165 | 0.2 |
| MMSE (Score) | 23.47 ± 2.80 b.c | 21.92–25.02 | 28.13 ± 2.26 a | 26.88–29.39 | 28.57 ± 1.83 a | 27.52–29.63 | 21.572 | 0.000 | 0.8 |
| IGF-1 (ng.mL−1) | 92.34 ± 22.80 b.c | 79.72–104.96 | 109.33 ± 28.74 a | 93.41–125.24 | 127.14 ± 51.56 a | 97.37–156.91 | 3.366 | 0.044 | 0.4 |
M ± SD = means and standard deviation; CI = confidence interval (CI 95%); § = one-factor multivariate analysis (Group); Eta2 = effect size; a,b,c = significant post hoc Bonferroni.
Intergroup comparison pre- and post-test of aerobic capacity (VO2max), maximum muscular strength (MS) of upper limbs (UL), lower limbs (LL), cognitive state (MMSE), and growth factor concentration (IGF-1).
| Variables | CG ( | ES | AG ( | ES | RG ( | ES | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |||||||
| VO2max. (mL·kg1·min−1) | 16.13 ± 1.80 | 15.79 ± 2.15 | 0.451 b | 0.3 | 16.02 ± 2.06 | 16.59 ± 1.43 | 0.030 b | 0.7 | 16.69 ± 1.10 | 16.91 ± 1.02 | 0.105 a | 0.5 |
| MS UL (kg) | 13.67 ± 1.91 | 13.47 ± 2.77 | 0.745 a | 0.1 | 14.40 ± 2.38 | 21.40 ± 4.75 | 0.010 b | 1.2 | 14.29 ± 2.58 | 23.57 ± 4.13 | 0.011 b | 2.4 |
| MS LL (kg) | 44.53 ± 3.50 | 44.13 ± 4.69 | 0.531 a | 0.2 | 47.20 ± 3.91 | 64.33 ± 18.46 | 0.003 a | 0.9 | 47.43 ± 3.88 | 77.79 ± 26.07 | 0.001 b | 1.1 |
| MMSE (Score) | 24.33 ± 3.52 | 23.47 ± 2.80 | 0.316 a | 0.3 | 26.80 ± 2.76 | 28.13 ± 2.26 | 0.011 b | 0.8 | 26.43 ± 2.65 | 28.57 ± 1.83 | 0.004 b | 1.0 |
| IGF-1 (ng·mL−1) | 91.41 ± 23.10 | 92.34 ± 22.80 | 0.347 a | 0.3 | 107.88 ± 28.56 | 109.33 ± 28.74 | 0.014 a | 0.1 | 105.42 ± 39.08 | 127.14 ± 51.56 | 0.005 a | 0.9 |
M ± SD = means and standard deviation; CI = confidence interval (CI 95%); a = Student’s t test; b = Wilcoxon test; ES = effect size.